The state of Maryland currently has 18 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Baltimore, Bethesda, Rockville and Annapolis.
Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
NCT05636852
Recruiting
Previous studies showed that a dose of 8 millicuries of Altropane was appropriate for imaging patients with suspected Parkinson's disease. This study will determine if a lower dose (5 millicuries) would suffice.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/02/2024
Locations: Johns Hopkins University, Baltimore, Maryland
Conditions: Parkinson Disease, Movement Disorders
Register for Updates
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT04477785
Recruiting
The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Gender:
All
Ages:
30 years and above
Trial Updated:
12/13/2023
Locations: Johns Hopkins University, Baltimore, Maryland
Conditions: Parkinson Disease
Register for Updates
Automated Imaging Differentiation of Parkinsonism
NCT05913687
Recruiting
The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.
Gender:
All
Ages:
Between 40 years and 80 years
Trial Updated:
11/13/2023
Locations: Johns Hopkins University, Lutherville, Maryland
Conditions: Parkinson Disease, Multiple System Atrophy, Parkinson Variant, Progressive Supranuclear Palsy
Register for Updates
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis
NCT05824728
Recruiting
This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease. Participants will be asked to complete up to 5 in-person study visits over approximately 20 weeks. Participants will receive both AGB101 and a placebo to take once a day for 6 weeks, with a 4-week washout in between. Participation will also involve physical/neurological exams, questionnaires, paper and pencil tests, providing blood and u... Read More
Gender:
All
Ages:
Between 40 years and 85 years
Trial Updated:
10/11/2023
Locations: Johns Hopkins, Baltimore, Maryland
Conditions: Parkinson Disease Psychosis
Register for Updates
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
NCT04846010
Recruiting
Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function disorder, kidney function failure, different. No matter how complicated the systems showed in the clinic, all of the symptoms are due to the specifi... Read More
Gender:
All
Ages:
All
Trial Updated:
05/23/2021
Locations: All Natural Medicine Clinic, LLC, Rockville, Maryland
Conditions: Sequelae of; Infection, Post Infection Glomerulonephritis, Post-Infectious Peripheral Neuralgia, Post-Infectious Disorder (Disorder), Post-Infectious Arthritis, Post-Infectious Polyneuritis, Post-Infectious Parkinsonism, Post-Infectious Hypothyroidism, Post Infectious Osteoarthritis, Anxiety Disorders, Depression, Depression, Anxiety, Depression, Bipolar, Insomnia, GERD, Gastro Esophageal Reflux, Hepatitis, Glomerulonephritis
Register for Updates
Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic
NCT04720118
Recruiting
The purpose of this research study is to examine the relationship between personal characteristics and satisfaction with care in those diagnosed with Parkinson's disease during the COVID-19 pandemic. Participants will take 4 different surveys regarding their satisfaction with care throughout the duration of the COVID-19 pandemic. The surveys in total should not take more than 30 minutes to complete
Gender:
All
Ages:
18 years and above
Trial Updated:
03/30/2021
Locations: Towson University, Towson, Maryland
Conditions: Parkinson Disease, Covid19, Satisfaction, Patient, Quality of Life
Register for Updates